Cargando…
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Neutralizing agents against SARS-CoV-2 are urgently needed for the treatment and prophylaxis of COVID-19. Here, we present a strategy to rapidly identify and assemble synthetic human variable heavy (VH) domains toward neutralizing epitopes. We constructed a VH-phage library and targeted the angioten...
Autores principales: | Bracken, Colton J., Lim, Shion A., Solomon, Paige, Rettko, Nicholas J., Nguyen, Duy P., Zha, Beth Shoshana, Schaefer, Kaitlin, Byrnes, James R., Zhou, Jie, Lui, Irene, Liu, Jia, Pance, Katarina, Zhou, Xin X., Leung, Kevin K., Wells, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356808/ https://www.ncbi.nlm.nih.gov/pubmed/33082574 http://dx.doi.org/10.1038/s41589-020-00679-1 |
Ejemplares similares
-
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
por: Bracken, Colton J., et al.
Publicado: (2020) -
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
por: Lim, Shion A., et al.
Publicado: (2021) -
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020) -
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020) -
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
por: Miersch, Shane, et al.
Publicado: (2022)